Again, the effect was more pronounced in AM from patients with IPF (CCL2: p<0.001; IL-1ra: p<0.001) compared to AM from healthy donors (CCL2: p=0.033, IL-1ra: p=0.01). The gene discussed is CCL2; the disease is idiopathic pulmonary fibrosis.